The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ANAPTYSBIO INC | COM | 032724106 | 56,517 | 2,628,678 | SH | OTR | 1 | 0 | 2,628,678 | 0 | |
| APTEVO THERAPEUTICS INC | COM NEW | 03835L207 | 64,504 | 1,760,000 | SH | OTR | 1 | 0 | 1,760,000 | 0 | |
| BCTG ACQUISITION CORP | COM | 05492W103 | 5,363 | 468,750 | SH | OTR | 1 | 0 | 468,750 | 0 | |
| COHERUS BIOSCIENCES INC | COM | 19249H103 | 11,297 | 650,000 | SH | OTR | 1 | 0 | 650,000 | 0 | |
| EQUILLIUM INC | COM | 29446K106 | 3,210 | 600,000 | SH | OTR | 1 | 0 | 600,000 | 0 | |
| LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 36,493 | 9,405,490 | SH | OTR | 1 | 0 | 9,405,490 | 0 | |
| ODONATE THERAPEUTICS INC | COM | 676079106 | 297,880 | 15,514,566 | SH | OTR | 1 | 0 | 15,514,566 | 0 | |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 6,414 | 200,000 | SH | OTR | 1 | 0 | 200,000 | 0 | |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 162,627 | 2,965,485 | SH | OTR | 1 | 0 | 2,965,485 | 0 | |
| VINCERA PHARMA INC | UNIT 12/24/2025 | 92731L205 | 9,630 | 500,000 | SH | OTR | 1 | 0 | 500,000 | 0 | |
| VINCERA PHARMA INC | *W EXP 12/24/202 | 92731L114 | 1,090 | 330,205 | SH | OTR | 1 | 0 | 330,205 | 0 | |